N, A., S, B., G, Y., H, A., A, A., M, M., . . . N, A. (2021). Author Correction: Tankyrase inhibitor XAV-939 enhances osteoblastogenesis and mineralization of human skeletal (mesenchymal) stem cells. Scientific reports, 11(1), 4559. https://doi.org/10.1038/s41598-021-83943-1
Chicago Style (17th ed.) CitationN, Almasoud, Binhamdan S, Younis G, Alaskar H, Alotaibi A, Manikandan M, Alfayez M, Kassem M, and AlMuraikhi N. "Author Correction: Tankyrase Inhibitor XAV-939 Enhances Osteoblastogenesis and Mineralization of Human Skeletal (mesenchymal) Stem Cells." Scientific Reports 11, no. 1 (2021): 4559. https://doi.org/10.1038/s41598-021-83943-1.
MLA (9th ed.) CitationN, Almasoud, et al. "Author Correction: Tankyrase Inhibitor XAV-939 Enhances Osteoblastogenesis and Mineralization of Human Skeletal (mesenchymal) Stem Cells." Scientific Reports, vol. 11, no. 1, 2021, p. 4559, https://doi.org/10.1038/s41598-021-83943-1.